Skin cancer — all decisions

The Board denied the Veteran's claim for service connection for skin cancer, finding that there was no evidence of a chronic disease in service or manifestation within one year of separation and that the Veteran's skin cancer was less likely than not related to his active service, including exposures to asbestos, Agent Orange, or radiation.

The Board remands the Veteran's claim for service connection for skin cancer to obtain additional evidence and an adequate etiology opinion.

The Board granted service connection for skin cancer, type II diabetes mellitus, hypertension, allergic rhinitis, and chronic sinusitis based on presumptive exposure to herbicides. Peripheral neuropathy of the right and left lower extremities was also granted due to their relationship with the Veteran's service-connected diabetes.

The Board granted service connection for malignant melanoma, finding it to be at least as likely as not due to in-service exposure to herbicides.

The Board granted service connection for heart condition, hypertension, prostate cancer, and skin cancer due to in-service herbicide exposure but denied service connection for bilateral hearing loss, tinnitus, and obstructive sleep apnea.

The Board granted service connection for scars resulting from surgery for malignant melanoma incurred during active duty service and remanded the other claims for further development.

The Board remands all claims for service connection due to a pre-decisional duty to assist error and an insufficient VA examination.

The Board denied service connection for melanoma as the evidence did not support a medical nexus between the Veteran's condition and his active service.

The appeal for service connection for dementia, basal cell carcinoma (right cheek - claimed as skin cancer), squamous cell carcinoma (nose - claimed as skin cancer), and left ear melanoma (to include lymph node removal - claimed as skin cancer) was dismissed due to the appellant's withdrawal of the appeal.

The Board granted a 30 percent rating for skin neoplasm with painful scars from November 19, 2008, to prior to December 16, 2022, and a 10 percent rating for residual trunk and extremities scars from November 19, 2008, to prior to July 22, 2022.

The Board granted service connection for seborrheic dermatitis affecting the scalp, face, left arm, and torso but denied service connection for actinic keratosis on the nose and nonmelanoma skin cancer on the nose.

The Board remands the claim for a skin disability to obtain an addendum medical opinion regarding whether the Veteran's skin disability is secondary to his service-connected liver transplant.

The Board granted service connection for malignant melanoma and residual scarring secondary to malignant melanoma based on the evidence of record.

The Board granted restoration of a 100 percent disability rating for skin cancer, squamous cell and basal cell status-post (s/p) excisions due to the RO's failure to properly consider improvement in the Veteran's ability to function under ordinary conditions of life and work.

The Board remands the matter of entitlement to service connection for skin cancer due to a procedural error in notifying the Veteran of his right to a hearing.

The Board remands the claims for service connection for various disabilities, including back, neck, knee, upper and lower extremity neurological, kidney, bowel blockage, skin cancer, and hemorrhoids, due to missing records and inadequate development of evidence.

The Board remands the claim for service connection for skin cancer to obtain a VA examination and medical opinion regarding its etiology, particularly concerning potential herbicide exposure during service.

The Board granted service connection for PTSD and remanded the claim for skin cancer due to a pre-decisional, duty-to-assist error.

The Board remands the claim for service connection of melanoma to obtain an addendum opinion addressing whether the Veteran's melanoma is related to in-service sun exposure.

The Board remands the claims for service connection for non-Hodgkin's lymphoma, malignant melanoma of the back status post excision, and metastatic squamous cell carcinoma of the neck status post tonsillectomy due to a need for additional development.